Publications by authors named "Sharon Pelles"

Claim this Profile
M
Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients-A New Promise? Preliminary Results.
Ron Batash, Noam Asna, Sara HaJ Ali, Tatiana Charkovsky, Murad Asali, Sharon Pelles

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysglycemia in non-functioning pancreatic neuroendocrine tumors (NF-PNET): Further insights into an under recognized entity.
Esther Osher, Ravit Geva, Ido Wolf, Karen Tordjman, Joseph Klausner, Sharon Pelles

J Clin Transl Endocrinol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal stromal tumor of the rectum.
Ami Schattner, Yair Glick, Osnat Sher, Sharon Pelles

Am J Med Sci· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors.
Esther Osher, Eiman Shalabna, Joseph M Klausner, Yona Greenman, Naftali Stern, Sharon Pelles

Biomedicines· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Position paper: Teaching breaking bad news (BBN) to undergraduate medical students.
Orit Karnieli-Miller, Sharon Pelles, Dafna Meitar

Patient Educ Couns· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-head comparison of [Ga]Ga-FAPI-04 and [F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma.
Jonathan Kuten, Charles Levine, Ofer Shamni, Sharon Pelles, Ido Wolf

Eur J Nucl Med Mol Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncologic patients' misconceptions may impede enrollment into clinical trials: a cross-sectional study.
Nethanel Asher, Ari Raphael, Ido Wolf, Sharon Pelles, Ravit Geva

BMC Med Res Methodol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer.
Shira Peleg Hasson, Barliz Waissengrin, Eliya Shachar, Marah Hodruj, Rochelle Fayngor, Sharon Pelles

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis.
Barliz Waissengrin, Dan Mirelman, Sharon Pelles, Felix Bukstein, Deborah T Blumenthal

Ther Adv Med Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Reply.
Ido Wolf, Barliz Waissengrin, Sharon Pelles

Oncologist· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking Bad News via Telemedicine: A New Challenge at Times of an Epidemic.
Ido Wolf, Barliz Waissengrin, Sharon Pelles

Oncologist· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations.
Tali Ofir Dovrat, Ethan Sokol, Garrett Frampton, Eliya Shachar, Sharon Pelles

Cancer Biol Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly carboplatin with paclitaxel compared to standard three-weekly treatment in advanced epithelial ovarian carcinoma--a retrospective study.
Tamar Safra, Sivan Shamai, Julia Greenberg, Anat Veizman, Shulem Shpigel, Sharon Pelles

Gynecol Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis